Vaxfab Enterprises Reports ₹225 Crore Loss in Q2 FY26 Despite Revenue Surge
Vaxfab Enterprises Limited, an Ahmedabad-based textile trading company, reported a net loss of ₹224.99 crore for Q2 FY26, contrasting with a profit of ₹38.73 crore in the previous quarter. Revenue from operations increased significantly to ₹5,504.09 crore from ₹1,457.08 crore. Total expenses rose to ₹5,432.00 crore, outpacing revenue growth. Inventories increased to ₹8,238.19 crore, while cash and cash equivalents improved to ₹121.96 crore.

*this image is generated using AI for illustrative purposes only.
Vaxfab Enterprises Limited , a textile trading company based in Ahmedabad, has reported a significant net loss of ₹224.99 crore for the quarter ended September 30, 2025 (Q2 FY26). This marks a stark contrast to the profit of ₹38.73 crore recorded in the previous quarter. The financial results, approved by the company's board on November 13, 2025, reveal a complex picture of the company's performance.
Revenue Growth Amidst Losses
Despite the substantial loss, Vaxfab Enterprises saw a notable increase in its total income. The company's revenue from operations surged to ₹5,504.09 crore in Q2 FY26, compared to ₹1,457.08 crore in the previous quarter. This significant jump in revenue indicates a considerable expansion in business activity during the period.
Financial Highlights
| Particulars (₹ in Crore) | Q2 FY26 | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue from Operations | 5,504.09 | 1,457.08 | 1,066.93 |
| Total Income | 5,162.48 | 1,394.24 | 1,052.81 |
| Total Expenses | 5,432.00 | 1,343.78 | 1,875.53 |
| Net Profit/(Loss) | (224.99) | 38.73 | (822.72) |
| EPS (₹) | (2.68) | 0.46 | (9.79) |
Operational Challenges
The dramatic shift from profit to loss can be attributed to a substantial increase in expenses. The company's total expenses for Q2 FY26 stood at ₹5,432.00 crore, a significant rise from ₹1,343.78 crore in the previous quarter. This surge in expenses outpaced the growth in revenue, leading to the reported loss.
Inventory and Trade Receivables
Vaxfab Enterprises reported a substantial increase in inventories, rising to ₹8,238.19 crore as of September 30, 2025, compared to ₹6,627.27 crore at the end of the previous financial year. This increase in inventory levels may indicate challenges in sales conversion or a strategic build-up for anticipated future demand.
Cash Flow and Liquidity
The company's cash and cash equivalents stood at ₹121.96 crore at the end of Q2 FY26, showing an improvement from ₹24.35 crore at the end of the previous financial year. This increase in liquidity may provide some cushion as the company navigates through its current operational challenges.
Market Position and Outlook
While the loss is concerning, the substantial increase in revenue suggests that Vaxfab Enterprises is expanding its market presence in the textile trading sector. However, the company will need to address its rising expenses and operational inefficiencies to return to profitability.
The board of directors and management will likely focus on cost optimization strategies and improving operational efficiency in the coming quarters. Investors and market analysts will be closely watching how the company manages its inventory levels and converts its increased revenue into profitability.
As Vaxfab Enterprises continues to operate in the dynamic textile trading industry, its ability to balance growth with profitability will be crucial for its future performance and market position.
Historical Stock Returns for Vaxfab Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.99% | -4.27% | +8.97% | +165.42% | +369.12% | +131.42% |




























